東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Protein-based therapeutics

Singh, Dev Bukhsh.

FindBook

Google Book

Amazon

博客來

Protein-based therapeutics

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Protein-based therapeutics/ edited by Dev Bukhsh Singh, Timir Tripathi.
其他作者:	Singh, Dev Bukhsh.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	ix, 384 p. :ill., digital ;24 cm.
內容註:	Chapter 1_Introduction to Protein Therapeutics. -- Chapter 2_Clinical Applications of Protein-based Therapeutics Against Various Diseases. -- Chapter 3_Protein Engineering Methods for the Design of Protein Therapeutics -- Chapter 4_Recombinant Production of Therapeutic Proteins -- Chapter 5_Antibodies as Protein Therapeutics -- Chapter 6_Streptokinase: The Success Story of a Therapeutic Protein -- Chapter 7_Strategies for Formulation and Systemic Delivery of Therapeutic Proteins -- Chapter 8_Approved Protein Therapeutics and Their Biochemical Targets -- Chapter 9_Pharmacogenetic Biomarkers of Protein Therapeutics -- Chapter 10_Immunogenicity of Therapeutic Proteins -- Chapter 11_Efficacy and Safety Issues of Therapeutic Proteins -- Chapter 12_Emerging Trends, Challenges, and Opportunities in Protein Therapeutics -- Chapter 13_Biosimilar, Biobetter & Biosuperior Therapeutic Proteins -- Chapter 14_Therapeutic Protein-based Vaccines.
Contained By:	Springer Nature eBook
標題:	Proteins - Therapeutic use. -
電子資源:	https://doi.org/10.1007/978-981-19-8249-1
ISBN:	9789811982491

Protein-based therapeutics
Protein-based therapeutics[electronic resource] /edited by Dev Bukhsh Singh, Timir Tripathi. - Singapore :Springer Nature Singapore :2023. - ix, 384 p. :ill., digital ;24 cm.

Chapter 1_Introduction to Protein Therapeutics. -- Chapter 2_Clinical Applications of Protein-based Therapeutics Against Various Diseases. -- Chapter 3_Protein Engineering Methods for the Design of Protein Therapeutics -- Chapter 4_Recombinant Production of Therapeutic Proteins -- Chapter 5_Antibodies as Protein Therapeutics -- Chapter 6_Streptokinase: The Success Story of a Therapeutic Protein -- Chapter 7_Strategies for Formulation and Systemic Delivery of Therapeutic Proteins -- Chapter 8_Approved Protein Therapeutics and Their Biochemical Targets -- Chapter 9_Pharmacogenetic Biomarkers of Protein Therapeutics -- Chapter 10_Immunogenicity of Therapeutic Proteins -- Chapter 11_Efficacy and Safety Issues of Therapeutic Proteins -- Chapter 12_Emerging Trends, Challenges, and Opportunities in Protein Therapeutics -- Chapter 13_Biosimilar, Biobetter & Biosuperior Therapeutic Proteins -- Chapter 14_Therapeutic Protein-based Vaccines.

This book provides an overview of the essential characteristics and clinical applications of therapeutic proteins against human diseases, including cancers, immune disorders, infections, and other diseases. It presents the latest advancements in protein engineering techniques for producing desirable therapeutic proteins. The book also covers the strategies used to formulate and deliver systemic therapeutic proteins, approved protein therapeutics and their targets, and pharmacogenetic biomarkers. Further, it discusses challenges associated with the clinical implications of therapeutic proteins, including safety, immunogenicity, protein stability, degradation, and efficacy. It illustrates the development of biosimilar antibodies, optimization strategies for producing biobetter antibodies, and presents fundamental concepts about biosuperior therapeutics. Lastly, it includes a discussion about protein-based vaccines against bacterial and viral infections.

ISBN: 9789811982491

Standard No.: 10.1007/978-981-19-8249-1doiSubjects--Topical Terms:

1005397
Proteins
--Therapeutic use.

LC Class. No.: RS431.P75 / P76 2023

Dewey Class. No.: 615.3

Protein-based therapeutics
LDR:02951nmm a2200349 a 4500 001 2315419
003 DE-He213
005 20230301014727.0
006 m d
007 cr nn 008maaau
008 230902s2023 si s 0 eng d
020 $a 9789811982491 $q (electronic bk.)
020 $a 9789811982484 $q (paper)
024 7 $a 10.1007/978-981-19-8249-1 $2 doi
035 $a 978-981-19-8249-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.P75 $b P76 2023
072 7 $a MMZ $2 bicssc
072 7 $a MJC $2 bicssc
072 7 $a PSY028000 $2 bisacsh
072 7 $a MKZ $2 thema
072 7 $a MJC $2 thema
082 0 4 $a 615.3 $2 23
090 $a RS431.P75 $b P967 2023
245 0 0 $a Protein-based therapeutics $h [electronic resource] / $c edited by Dev Bukhsh Singh, Timir Tripathi.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a ix, 384 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1_Introduction to Protein Therapeutics. -- Chapter 2_Clinical Applications of Protein-based Therapeutics Against Various Diseases. -- Chapter 3_Protein Engineering Methods for the Design of Protein Therapeutics -- Chapter 4_Recombinant Production of Therapeutic Proteins -- Chapter 5_Antibodies as Protein Therapeutics -- Chapter 6_Streptokinase: The Success Story of a Therapeutic Protein -- Chapter 7_Strategies for Formulation and Systemic Delivery of Therapeutic Proteins -- Chapter 8_Approved Protein Therapeutics and Their Biochemical Targets -- Chapter 9_Pharmacogenetic Biomarkers of Protein Therapeutics -- Chapter 10_Immunogenicity of Therapeutic Proteins -- Chapter 11_Efficacy and Safety Issues of Therapeutic Proteins -- Chapter 12_Emerging Trends, Challenges, and Opportunities in Protein Therapeutics -- Chapter 13_Biosimilar, Biobetter & Biosuperior Therapeutic Proteins -- Chapter 14_Therapeutic Protein-based Vaccines.
520 $a This book provides an overview of the essential characteristics and clinical applications of therapeutic proteins against human diseases, including cancers, immune disorders, infections, and other diseases. It presents the latest advancements in protein engineering techniques for producing desirable therapeutic proteins. The book also covers the strategies used to formulate and deliver systemic therapeutic proteins, approved protein therapeutics and their targets, and pharmacogenetic biomarkers. Further, it discusses challenges associated with the clinical implications of therapeutic proteins, including safety, immunogenicity, protein stability, degradation, and efficacy. It illustrates the development of biosimilar antibodies, optimization strategies for producing biobetter antibodies, and presents fundamental concepts about biosuperior therapeutics. Lastly, it includes a discussion about protein-based vaccines against bacterial and viral infections.
650 0 $a Proteins $x Therapeutic use. $3 1005397
650 0 $a Protein drugs. $3 869628
650 1 4 $a Therapeutics. $3 680391
650 2 4 $a Diseases. $3 618693
650 2 4 $a Proteins. $3 558769
700 1 $a Singh, Dev Bukhsh. $3 3526472
700 1 $a Tripathi, Timir. $3 3529260
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-8249-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)